The global Active Pharmaceutical Ingredients/APImarket was valued at USD 157.87billion in 2016 and is projected to reach USD 271.97billionby 2025, growing at a CAGR of 6.23% from 2017 to 2025.
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. With increased investments and focus on API and its applications in R&D, the market is expected to grow at a high rate during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Prevalence of chronic disorders
1.2 Increase cases of cancer
1.3 Technological advancements in API
1.4 Increasing geriatric population
1.5 Increasing scope of generics
1.6 Expansion of applications of biopharmaceuticals
2. Market Restraints
2.1 Unfavorable Drug pricing poilicies
2.2 Stringent regulations
Market Segmentation:
1. By Therapeutic Application:
1.1 Oncology
1.2 Cardiovascular Disease
1.3 Diabetes
1.4 Central Nervous System and Neurological Disorders
1.5 Endocrinology
1.6 Other Therapeutic Applications
2. By Type of Drug:
2.1 Prescription Drugs
2.2 Over-The-Counter Drugs
2.3 Active Pharmaceutical Ingredients Market, By Potency
2.3.1 Low to Moderate Potency Active Pharmaceutical Ingredients
2.3.2 Potent to Highly Potent Active Pharmaceutical Ingredients
3. By Type of Synthesis:
3.1 Synthetic Active Pharmaceutical Ingredients
3.1.1 Innovative Synthetic APIs
3.1.2 Generic Synthetic APIs
3.2 Biotech Active Pharmaceutical Ingredients
3.2.1 By Type
3.2.1.1 Innovative Biotech APIs
3.2.1.2 Biosimilars
3.2.2 By Product
3.2.2.1 Monoclonal Antibodies
3.2.2.2 Vaccines
3.2.2.3 Hormones and Growth Factors
3.2.2.4 Cytokines
3.2.2.5 Fusion Proteins
3.2.2.6 Therapeutic Enzymes
3.2.2.7 Blood Factors
3.2.3 By Expression System
3.2.3.1 Mammalian Expression Systems
3.2.3.2 Microbial Expression Systems
3.2.3.3 Yeast Expression Systems
3.2.3.4 Plant Expression Systems
3.2.3.5 Insect Expression Systems
4. By Type of manufacturer:
4.1 Captive Manufacturers
4.2 Merchant API Manufacturers
5. By Type:
5.1 Innovative Active Pharmaceutical Ingredients
5.2 Generic Active Pharmaceutical Ingredients
6. By Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Pfizer, Inc.
2. Novartis International AG
3. Sanofi
4. BoehringerIngelheim
5. Bristol-Myers Squibb
6. Teva Pharmaceutical Industries Ltd.
7. ELI Lilly and Company
8. Glaxosmithkline PLC
9. Merck & Co., Inc.
10. Abbvie Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Active Pharmaceutical Ingredients/APImarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY THERAPEUTIC APPLICATION:
5.1 Oncology
5.2 Cardiovascular Disease
5.3 Diabetes
5.4 Central Nervous System and Neurological Disorders
5.5 Endocrinology
5.6 Other Therapeutic Applications
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE OF DRUG:
6.1 Prescription Drugs
6.2 Over-The-Counter Drugs
6.3 Active Pharmaceutical Ingredients Market, By Potency
6.3.1 Low to Moderate Potency Active Pharmaceutical Ingredients
6.3.2 Potent to Highly Potent Active Pharmaceutical Ingredients
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE OF SYNTHESIS:
7.1 Synthetic Active Pharmaceutical Ingredients
7.1.1 Innovative Synthetic APIs
7.1.2 Generic Synthetic APIs
7.2 Biotech Active Pharmaceutical Ingredients
7.2.1 By Type
7.2.1.1 Innovative Biotech APIs
7.2.1.2 Biosimilars
7.2.2 By Product
7.2.2.1 Monoclonal Antibodies
7.2.2.2 Vaccines
7.2.2.3 Hormones and Growth Factors
7.2.2.4 Cytokines
7.2.2.5 Fusion Proteins
7.2.2.6 Therapeutic Enzymes
7.2.2.7 Blood Factors
7.2.3 By Expression System
7.2.3.1 Mammalian Expression Systems
7.2.3.2 Microbial Expression Systems
7.2.3.3 Yeast Expression Systems
7.2.3.4 Plant Expression Systems
7.2.3.5 Insect Expression Systems
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE OF MANUFACTURER:
8.1 Captive Manufacturers
8.2 Merchant API Manufacturers
9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE:
9.1 Innovative Active Pharmaceutical Ingredients
9.2 Generic Active Pharmaceutical Ingredients
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Pfizer, Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Novartis International AG
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Sanofi
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 BoehringerIngelheim
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Bristol-Myers Squibb
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 ELI Lilly and Company
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Glaxosmithkline PLC
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Merck & Co., Inc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Development
12.10 Abbvie Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Development
13 Appendix
13.1 Related Reports
The Freeze-drying Pharmaceutical Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Active RFID Asset Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
The Pharmaceutical Cost Management Platforms Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Pharmaceutical Purified Water Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Pharmaceutical Intellectual Property Protection Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitiv...
The Pharmaceutical Safety Assessment Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...